James Garner

Company: Kazia Therapeutics Limited
Job title: Chief Executive Officer
Seminars:
Panel Discussion: GBM AGILE Goes Worldwide: Taking a Deep Dive Into How Well It Has Worked So Far & What Promise It Brings With Expansion 9:00 am
Reflecting on more than 3 years of progress – lessons learned to date and plans/goals for the next 3+ years Stakeholder perspectives – industry, clinical/scientific investigators, and patient advocates Adaptive Global Innovative Learning Environment (AGILE): Focusing on the “LE” in AGILERead more
day: Conference Day One
PI3K Inhibition With Hypoinsulinaema – A Novel Approach to Maximizing the Impact of Targeted Therapy 12:00 pm
Reviewing the role of the PI3K pathway in glioblastoma Evaluating the rationale for combining PI3K pathway inhibition with hypoinsulinaemia Overview of an ongoing clinical trial to explore the combinationRead more
day: Conference Day Two